Subtype-specific regulation of equilibrative nucleoside transporters by protein kinase CK2

Biochemical Journal

Volumn 386, Issue 2, 2005, Pages 281-289

  Stolk, Meaghan ^a   Cooper, Elizabeth ^a   Vilk, Greg ^a   Litchfield, David W ^a   Hammond, James R ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

2 chloroadenosine; Adenosine; Nitrobenzylthioinosine; Phosphorylation; Regulation; Transporter

Indexed keywords

BINDING ENERGY; CATALYSIS; CELL MEMBRANES; ENZYME INHIBITION; GENES; RNA;

NUCLEOSIDE FLUX; OSTEOSARCOMA CELLS; PHOSPHORYLATION; PLASMA MEMBRANE;

ENZYMES;

CASEIN KINASE II; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 2; NITROBENZYLTHIOINOSINE;

ARTICLE; CELL MEMBRANE TRANSPORT; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; NUCLEOSIDE TRANSPORT; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; TRANSPORT KINETICS;

2-CHLOROADENOSINE; BONE NEOPLASMS; CASEIN KINASE II; CATALYTIC DOMAIN; CELL LINE, TUMOR; COMPUTER SYSTEMS; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; EQUILIBRATIVE-NUCLEOSIDE TRANSPORTER 2; FORMYCINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NUCLEOSIDES; OSTEOSARCOMA; POLYMERASE CHAIN REACTION; SUBSTRATE SPECIFICITY; THIOINOSINE; TRANSFECTION; TRITIUM;

MAMMALIA;

EID: 14844325341     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20041571     Document Type: Article

References (51)

1. Hyde, R. J., Cass, C. E., Young, J. D. and Baldwin, S. A. (2001) The ENT family of eukaryote nucleoside and nucleobase transporters: recent advances in the investigation of structure/function relationships and the identification of novel isoforms. Mol. Membr. Biol. 18, 53-63
2. Van Belle, H, (1993) Nucleoside transport inhibition: a therapeutic approach to cardioprotection via adenosine? Cardiovasc. Res. 27, 68-76
3. Belt, J. A., Marina, N.M., Phelps, D. A. and Crawford, C. R. (1993) Nucleoside transport in normal and neoplastic ceils. Adv. Enzyme Regul. 33, 235-252
4. Damaraju, V. L., Damaraju, S., Young, J. D., Baldwin, S. A., MacKey, J., Sawyer, M. B. and Cass, C. E. (2003) Nucleoside anticancer drugs: the role of nucleoside transporters in resistance to cancer chemotherapy. Oncogene 22, 7524-7536
5. Gray, J. H., Owen, R. P. and Giacomini, K. M. (2004) The concentrative nucleoside transporter family, SLC28. Pflugers Arch. 447, 728-734
6. Baldwin, S. A., Beal, P. R., Yao, S. Y., King, A. E., Cass, C. E. and Young, J. D. (2004) The equilibrative nucleoside transporter family, SLC29. Pflugers Arch. 447, 735-743
7. Griffiths, M., Yao, S. Y., Abidi, F., Phillips, S. E., Cass, C. E., Young, J. D. and Baldwin, S. A. (1997) Molecular cloning and characterization of a nitrobenzylthioinosine-insensitive (ei) equilibrative nucleoside transporter from human placenta. Biochem. J. 328, 739-743
8. Griffiths, M., Beaumont, N., Yao, S. Y. M., Sundaram, M., Boumah, C. E., Davies, A., Kwong, F. Y. P., Coe, I., Cass, C. E., Young, J. D. and Baldwin, S. A. (1997) Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs. Nat. Med. 3, 89-93
9. Kiss, A., Farah, K., Kim, J., Garriock, R. J., Drysdale, T. A. and Hammond, J. R. (2000) Molecular cloning and functional characterization of inhibitor-sensitive (mENT1) and inhibitor-resistant (mENT2) equilibrative nucleoside transporters from mouse brain. Biochem. J. 352, 363-372
10. Handa, M., Choi, D., Caldeiro, R. M., Messing, R. O., Gordon, A. S. and Diamond, I. I. (2001) Cloning of a novel isoform of the mouse NBMPR-sensitive equilibrative nucleoside transporter (ENT1) lacking a putative phosphorylation site. Gene 262, 301-307
11. Faust, M. and Montenarh, M. (2000) Subcellular localization of protein kinase CK2. A key to its function? Cell Tissue Res. 301, 329-340
12. Litchfield, D. W. (2003) Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. Biochem. J. 369, 1-15
13. Guerra, B. and Issinger, O. G. (1999) Protein kinase CK2 and its role in cellular proliferation, development and pathology. Electrophoresis 20, 391-408
14. Ahmed, K., Davis, A. T., Wang, H., Faust, R. A., Yu, S. and Tawfic, S. (2000) Significance of protein kinase CK2 nuclear signaling in neopiasia. J. Cell. Biochem. Suppl. 35, 130-135
15. Pennycooke, M., Chaudary, N., Shuralyova, I., Zhang, Y. and Coe, I. R. (2001) Differential expression of human nucleoside transporters in normal and tumor tissue. Biochem. Biophys. Res. Commun. 280, 951-959
16. Cass, C. E., Dahlig, E., Lau, E. Y., Lynch, T. P. and Paterson, A. R. (1979) Fluctuations in nucleoside uptake and binding of the inhibitor of nucleoside transport, nitrobenzylthioinosine, during the replication cycle of HeLa cells. Cancer Res. 39, 1245-1252
17. Coe, I. R., Dohrman, D. P., Constantinescu, A., Diamond, I. and Gordon, A. S. (1996) Activation of cyclic AMP-dependent protein kinase reverses tolerance of a nucleoside transporter to ethanol. J. Pharmacol. Exp. Ther. 276, 365-369
18. Coe, I., Zhang, Y., McKenzie, T. and Naydenova, Z. (2002) PKC regulation of the human equilibrative nucleoside transporter, hENT1. FEBS Lett. 517, 201-205
19. Lee, C.-W. (1994) Decrease in equilibrative undine transport during monocytic differentiation of HL-60 leukaemia: involvement of protein kinase C. Biochem. J. 300, 407-412
20. Soler, C., Felipe, A., Mata, J. F., Casado, F. J., Celada, A. and Pastor-Anglada, M. (1998) Regulation of nucleoside transport by lipopolysaccharide, phorbol esters and tumor necrosis factor-alpha in human B-lymphocytes. J. Biol. Chem. 273, 26939-26945
21. Jones, K. W., Rylett, R. J. and Hammond, J. R. (1994) Effect of cellular differentiation on nucleoside transport in human neuroblastoma cells. Brain Res. 660, 104-112
22. Meckling-Gill, K. A. and Cass, C. E. (1992) Effects of transformation by v-fps on nucleoside transport in Rat-2 fibroblasts. Biochem. J. 282, 147-154
23. Baldwin, S. A., Mackey, J. R., Cass, C. E. and Young, J. D. (1999) Nucleoside transporters: molecular biology and implications for therapeutic development. Mol. Med. Today 5, 216-224
24. Cook, M. A. and Karmazyn, M. (1996) Cardioprotective actions of adenosine and adenosine analogs. EXS 76, 325-344
25. Sarno, S., Moro, S., Meggio, F., Zagotto, G., Dal Ben, D., Ghisellini, P., Battistutta, R., Zanotti, G. and Pinna, L. (2002) Toward the rational design of protein kinase casein kinase-2 inhibitors. Pharmacol. Ther. 93, 159-168
26. Vilk, G., Saulnier, R. B., St Pierre, R. and Litchfield, D. W. (1999) Inducible expression of protein kinase CK2 in mammalian cells. Evidence for functional specialization of CK2 isoforms. J. Biol. Chem. 274, 14406-14414
27. Stolk, M., Farah, K., Cooper, E., Vilk, G., Litchfield, D. W. and Hammond, J. R. (2002) Regulation of equilibrative nucleoside transporters by protein kinase CK2. Pharmacologist 44 (Suppl. 1), A40-A41
28. Hammond, J. R. and Johnstone, R. M. (1989) Soiubilization and reconstitution of a nucleoside-transport system from Ehrlich ascites-tumour cells. Biochem. J. 262, 109-118
29. Hammond, J. R. (2000) Interaction of a series of draflazine analogues with equilibrative nucleoside transporters: species differences and transporter subtype selectivity. Naunyn Schmiedebergs Arch. Pharmacol. 361, 373-382
30. Jarvis, S. M. and Young, J. D. (1980) Nucleoside transport in human and sheep erythrocytes: evidence that nitrobenzylthioinosine binds specifically to functional nucleoside-transport sites. Biochem. J. 190, 377-383
31. Cheng, Y. and Prusoff, W. H. (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (150) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099-3108
32. Plagemann, P. G. W. and Woffendin, C. (1989) Use of formycin B as a general substrate for measuring facilitated nucleoside transport in mammalian cells. Biochim. Biophys. Acta 1010, 7-15
33. Goh, L. B., Mack, P. and Lee, C. W. (1995) Nitrobenzylthioinosine-binding protein overexpression in human breast, liver, stomach and colorectal tumour tissues. Anticancer Res. 15, 2575-2579
34. Griffith, D. A. and Jarvis, S. M. (1996) Nucleoside and nucleobase transport systems of mammalian cells. Biochim. Biophys. Acta Rev. Biomembr. 1286, 153-181
35. Litchfield, D. W., Bosc, D. G., Canton, D. A., Saulnier, R. B., Vilk, G. and Zhang, C. (2001) Functional specialization of CK2 isoforms and characterization of isoform-specific binding partners. Mol. Cell. Biochem. 227, 21-29
36. Yamanaka, H., Kamatani, N., Nishida, Y., Nishioka, K. and Mikanagi, K. (1984) Relationship between phosphorylation and cytotoxicity of 2-chloroadenosine and 6-methylmercaptopurine riboside in human cells. Biochim. Biophys. Acta 798, 291-294
37. Jarvis, S. M., Martin, B. W. and Ng, A. S. (1985) 2-Chloroadenosine, a permeant for the nucleoside transporter. Biochem. Pharmacol. 34, 3237-3241
38. Koshiba, M., Kosaka, H., Nakazawa, T., Hayashi, N., Saura, R., Kitamura, N. and Kumagai, S. (2002) 2-Chloroadenosine but not adenosine induces apoptosis in rheumatoid fibroblasts independently of cell surface adenosine receptor signalling. Br. J. Pharmacol. 135, 1477-1486
39. Osses, N., Pearson, J. D., Yudilevich, D. L. and Jarvis, S. M. (1996) Hypoxanthine enters human vascular endothelial celis (ECV 304) via the nitrobenzylthioinosine-insensitive equilibrative nucleoside transporter. Biochem. J. 317, 843-848
40. Hammond, J. R. (1991) Comparative pharmacology of the nitrobenzylthioguanosine-sensitive and -resistant nucleoside transport mechanisms of Ehrlich ascites tumor cells. J. Pharmacol. Exp. Ther. 259, 799-807
41. Ward, J. L., Sherali, A., Mo, Z. P. and Tse, C. M. (2000) Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter- deficient PK15 cells. ENT2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine. J. Biol. Chem. 275, 8375-8381
42. Sperlagh, B., Baranyi, M., Hasko, G. and Vizi, E. S. (2004) Potent effect of interleukin-1 beta to evoke ATP and adenosine release from rat hippocampal slices. J. Neuroimmunol. 151, 33-39
43. Lebrin, F., Bianchini, L., Rabilloud, T., Chambaz, E. M. and Goldberg, Y. (1999) CK2alpha-protein phosphatase 2A molecular complex: possible interaction with the MAP kinase pathway. Mol. Cell. Biochem. 191, 207-212
44. Castelli, M., Camps, M., Leroy, D., Arkinstall, S., Rommel, C. and Nichols, A. (2004) MAP kinase phosphatase 3 (MKP3) interacts with and is phosphorylated by protein kinase CK2alpha J. Biol. Chem. 279, 44731-44739
45. Soler, C., Felipe, A., Garcia-Manteiga, J., Serra, M., Guillen-Gomez, E., Casado, F. J., MacLeod, C., Modolell, M., Pastor-Anglada, M. and Celada, A. (2003) Interferon-gamma regulates nucleoside transport systems in macrophages through signal transducer and activator of transduction factor 1 (STAT1)-dependent and -independent signalling pathways. Biochem. J. 375, 777-783
46. Mead, J. R., Hughes, T. R., Irvine, S. A., Singh, N. N. and Ramji, D. P. (2003) Interferon-gamma stimultes the expression of the inducible cAMP early repressor in macrophages through the activation of casein kinase 2. A potentially novel pathway for interferon-gamma-mediated inhibition of gene transcription. J. Biol. Chem. 278, 17741-17751
47. Jimenez, A., Pubill, D., Pallas, M., Camins, A., Llado, S., Camarasa, J. and Escubedo, E. (2000) Further characterization of an adenosine transport system in the mitochondrial fraction of rat testis. Eur. J. Pharmacol. 398, 31-39
48. Mani, R. S., Hammond, J. R., Marjan, J. M., Graham, K. A., Young, J. D., Baldwin, S. A. and Cass, C. E. (1998) Demonstration of equilibrative nucleoside transporters (hENT1 and hENT2) in nuclear envelopes of cultured human choriocarcinoma (BeWo) cells by functional reconstitution in proteoliposomes. J. Biol. Chem. 273, 30818-30825
49. Pisoni, R. L. and Thoene, J. G. (1989) Detection and characterization of a nucleoside transport system in human fibroblast lysosomes. J. Biol. Chem. 264, 4850-4856
50. Lai, Y., Tse, C. M. and Unadkat, J. D. (2003) Mitochondrial expression of the human equilibrative nucleoside transporter 1 (hENT1) results in enhanced mitochondrial toxicity of antiviral drugs. J. Biol. Chem. 279, 4490-4497
51. Baldwin, S. A., Barros, L. F. and Griffiths, M. (1995) Trafficking of glucose transporters - Signals and mechanisms. Biosci. Rep. 15, 419-426